Yayi He
Clinical trials sponsored by Yayi He, explained in plain language.
-
New cocktail therapy aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a combination of drugs (benmelstobart, anlotinib, and chemo) followed by chest radiation as a first treatment for people with extensive-stage small cell lung cancer that has spread. About 33 adults aged 18-75 will receive the treatment to see if it shrinks tumors…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Promising new cocktail aims to shrink lung tumors
Disease control Not yet recruitingThis study tests a new combination of drugs and radiation as a first treatment for people with limited-stage small cell lung cancer (LS-SCLC) that cannot be removed by surgery. The treatment includes an immunotherapy (benmelstobart), a drug that cuts off tumor blood supply (anlot…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 18, 2026 12:08 UTC